Article Information
History
- October 22, 2021.
Article Versions
- Version 1 (October 19, 2021 - 03:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tatjana Schwarz, M.Sc.1,*,
- Carolin Otto, MD2,*,
- Terry C. Jones, PhD1,
- Florence Pache, MD2,
- Patrick Schindler, MD2,
- Moritz Niederschweiberer2,
- Felix A. Schmidt, MD2,
- Christian Drosten, MD1,
- Victor M. Corman, MD1,3,#,§ and
- Klemens Ruprecht, MD2,#,§
- 1Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
- 2Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 3Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
- ↵§Co-Corresponding authors: Dr. med. Victor M. Corman, Institute of Virology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany, phone +49 30 450 625 095, fax +49 30 450 752 5907, e-mail: victor.corman{at}charite.de and Prof. Dr. med. Klemens Ruprecht, Department of Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany, phone: ++49 30 450 660 374, fax: ++49 30 450 560 922, e-mail: klemens.ruprecht{at}charite.de
Posted October 22, 2021.
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
